Keep Your Eyes on This Stock: Healthpeak Properties, Inc. (NYSE: HCP)

Healthpeak Properties, Inc. (NYSE: HCP) ended the last transaction at $35.78, with a change of -2.53%. The daily volume was calculated at 4822246 shares. The company has a market worth of $18007.72M. It holds an average volume of 2973.07K shares. In 52-week session, the stock hit the peak level of -5.67% and touched to lowest level of 34.61%.

Healthpeak Properties, Inc. (HCP) reported recently the public offering of 15,000,000 shares of its ordinary stock at a price of $35.00 per share in connection with its contract to sell its ordinary stock pursuant to the forward sale contract described below.  The underwriters have been granted a 30-day option to purchase up to an additional 2,250,000 shares of Healthpeak’s ordinary stock.

Healthpeak entered into a forward sale contract with an associate of BofA Securities (the “forward purchaser”).  The forward purchaser (or its associate) is predictable to borrow from third parties, and sell to the underwriters, the 15,000,000 shares of Healthpeak’s ordinary stock (or an aggregate of 17,250,000 shares if the underwriters exercise their option to purchase additional shares in full) in the offering.

Healthpeak has agreed to issue and deliver, upon physical settlement of such forward sale contract on one or more dates specified by Healthpeak within 12 months of entry into the forward sale contract, up to 15,000,000 shares of Healthpeak’s ordinary stock (or an aggregate of 17,250,000 shares if the underwriters exercise their option to purchase additional shares in full) to the forward purchaser.  In exchange for the shares, Healthpeak will receive cash proceeds per share equal to the applicable forward sale price per share, subject to certain adjustments as provided in the forward sale contract.

HCP has PEG ratio of 8.39 and price to cash ratio of 137.99. In the trailing 12 months period, return on assets ratio of the Company was 8.20% and return on equity ratio was 18.90% while its return on investment ratio was 3.60%. In the profitability analysis, net profit margin of the firm was recorded at 56.60% and operating profit margin was calculated at 21.20% while gross profit margin was measured as 57.60%. Beta factor, which measures the riskiness of the security, was registered at 0.22.